Abstract:The overactivation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signal transduction pathway has been examined in various carcinomas and is reported to be significantly correlated with prognosis. However, little is known with regard to the PI3K/Akt signal transduction pathway in advanced non-small cell lung carcinoma (NSCLC). The present study investigated the expression of PI3K and phosphorylated (p)-Akt protein and its clinical significance in NSCLC. The clinical records of 157 patients with NSCLC (70 stage I-IIIA and 87 stage IIIB-IV cases), consisting of 75 cases of squamous cell carcinoma and 82 cases of adenocarcinoma, together with 30 resected lung cancer tumor-adjacent tissue samples, were retrospectively evaluated. PI3K and p-Akt expression in the NSCLC and tumor-adjacent tissues were measured using an immunohistochemical method, and its correlation with the clinicopathological data and prognosis in advanced NSCLC was evaluated. PI3K and p-Akt expression was significantly higher in the cancer tissues (chi(2)=14.8455; P=0.001) than in the tumor-adjacent tissues (chi(2)=14.2615; P=0.001). The overexpression of p-Akt in stage I-IIIA NSCLC was associated with lymph node metastasis (chi(2)=6.1189; P=0.013) and tumor-node-metastasis (TNM) stage (chi(2)=8.9752; P=0.011), however, no correlation was observed with gender, age, pathological type and histological grade. The overexpression of p-Akt in stage IIIB-IV NSCLC was only associated with TNM stage (chi(2)=5.7501; P=0.016), and no correlation was observed with gender, age, Pathological type, histological grade and Eastern Cooperative Oncology Group (ECOG) performance status (PS). The overexpression of PI3K was not found to correlate with the aforementioned clinicopathological variables in all patients. Survival was significantly improved in advanced NSCLC with PI3K- and p-Akt-negative expression compared with PI3K- and p-Akt-positive expression [P13K: 17.70 months (95% confidence interval (CI), 15.11-20.28 mont hs) vs. 13.43 months (95% CI, 11.83-15.02 months); P=0.004; and p-Akt: 17.13 months (95% CI, 14.93-19.34 months) vs. 13.07 months (95% CI, 11.32-14.82 months); P=0.007]. Multivariate analysis showed that PI3K [hazard ratio (HR)=2.143; 95% CI, 1.211-3.790; P=0.009], p-Akt (HR=1.991; 95% CI, 1.009-3.927; P=0.047), TNM stage (HR=4.788; 95% CI, 2.591-8.848; P=0.001) and ECOG-PS (HR=3.272; 95% CI, 1.701-6.296; P=0.001) were independent predictors for survival in stage IIIB-IV NSCLC. These results indicated that p-Akt overexpression closely correlates with factors of an unfavorable prognosis in NSCLC. PI3K and p-Akt overexpression are independent markers of a poor prognosis in advanced NSCLC.

Expression and significance of phospho-Akt in malignant melanoma

Overexpression of Phosphorylated-Stat3 and Phosphorylated-Akt Correlated with the Invasion and Metastasis of Malignant Melanoma

Mutations of PTEN Gene in 117 Chinese Patients with Malignant Melanoma and Their Clinical Significance

[Phophorylated Akt Protein Expression in Non-Small Cell Lung Cancer].

Expression and clinical significance of pAkt in hepatocellular carcinoma

Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.

Expression and Clinical Significance of Akt and Phosphoryled Akt1 in Pancreatic Carcinoma

Expression and Clinical Significance of P-Akt in Pancreatic Carcinoma Using Tissue Microarray

Expression of phospho-MAPK in non-small cell cancer and its clinicopathological significance

Association of the Activation of the Mtor Pathway with Prognosis in Chinese Melanoma Patients.

[The Expression and Clinical Significance of AKT2, Phosphorylated AKT2 in Non-Small Cell Lung Cancer].

Tissue Microarray Analysis Reveals The Expression And Prognostic Significance Of Phosphorylated Akt(Thr308) In Oral Squamous Cell Carcinoma

Expression Of Ki-67 And Pakt In Colorectal Cancer Tissues And Their Clinical Significance

MMP2 expression is a prognostic marker for primary melanoma patients

Phosphorylated AKT Protein is Overexpressed in Human Peripheral T-cell Lymphomas and Predicts Decreased Patient Survival

Expression of P-Akt in Nasopharyngeal Carcinoma and Its Clinical Significance

Clinical significance of the phosphorylation of MAPK and protein expression of cyclin D1 in human osteosarcoma tissues.

Relationship between the expression of phospho-Akt level in breast cancers and clinical biology factors tissues

AKT-mediated regulation of chromatin ubiquitylation and tumorigenesis through Mel18 phosphorylation

The Prognostic Value of Phosphorylated Akt in Breast Cancer: A Systematic Review

Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma.